SlideShare a Scribd company logo
1 of 24
To File or Not to File: Threshold Patent
Application Disclosure Requirements and
Post-Filing Evidence Admissibility in the
U.S. and Foreign Countries
Presented By
Tracy Bornman
Crissa A. Seymour Cook
Thursday, September 11, 2014 
University of Missouri System
What and When?
• What kind of information, data, disclosure is
needed for meeting threshold requirements in
various countries?
• When do you need to/When can you present
this information, data, disclosure?
• What are the pitfalls and best practices?
United States
• Major issues:
– Written Description
– Enablement
– Best Mode
– Definiteness
• Addressed in 35 U.S.C. 112
• Inverse relationship to the level of
“predictability” of the field of the invention
US – Minimum Requirements
• Written Description
– Description of invention that demonstrates possession of
invention as of filing date
• Enablement
– Describe how to make and use invention
• Working examples, Prophetic examples
• Figures
– Some experimentation permitted…must not be undue
• Best Mode? Best practice to still include
• Definiteness: clarity and precision in terminology
United States – What and When?
• Written description, enablement, best mode,
and definiteness must be satisfied at time of
filing.
• How?
– Provide text to support different embodiments
– Include as much relevant data as possible
– Working examples typically included and generally
recommended
– Detailed drawing figures (picture worth a thousand words)
United States – Post-Filing
• During patent prosecution, evidence may be submitted to
show:
– Sufficiency of original disclosure
• e.g., in vitro and/or in vivo test results consistent with
teachings of specification
– Utility/Enablement- operability of claimed invention –
confirmation of asserted utility
– Novelty- rebut allegation of inherency in prior art, demonstrate
prior art is non-enabling
– Nonobviousness- secondary considerations, e.g., unexpected
results, commercial success
– Establish level and knowledge of one of ordinary skill in the art
United States – Post-Filing
• During prosecution, evidence may NOT be
submitted to:
– Add new matter or data to the application
– Demonstrate that the invention has now been
enabled
• Any evidence must have a basis in the original
filing, or be used to support original
disclosure, and consistent with original
disclosure
Canada – Minimum Requirements
• Similar disclosure requirements as the U.S., set
forth in section 27 of the Canadian patent act:
– “Correct” and “full” description of the invention
– Enabling disclosure – “undue” experimentation
standard
– Best Mode
– Process claims require a description of the
necessary sequence, if applicable
• Utility – higher threshold
Canada – Minimum Requirements
• Utility Requirement – evolving issue
– Inventor has actually demonstrated utility prior to
the application filing date, or
– Inventor has data and a line of reasoning for sound
prediction of utility
– “Promise Doctrine” – what utility does the
disclosure promise of the invention?
Canada – Minimum Requirements
• Promise Doctrine:
– Requires the inventor to “soundly predict” how its
invention will be used and essentially prove via data in the
application hat the invention will successfully fulfill its
promise
• Considerations for satisfying utility:
– Avoid “over promising” - Do not include statements in the
description that could be read as a promise of a utility that
is not clearly supported
– Provide explicit statement linking data to utility and align
claim scope accordingly.
Canada – Post-Filing
• Post-filing evidence that is admissible:
– Adding matter that can be reasonably inferred
from application as filed
– Incorporating prior art so long as it is admitted* in
the specification that the matter is prior art with
respect to the application (benefit must be weighed
against treatment of admissions in U.S.)
• Canadian Examiners are under no obligation
to review post-filing submissions.
Canada – Post-Filing
• Post-filing evidence that is NOT admissible:
– Post-filing data is not permitted to support predictions
about a claim’s utility or soundness. 
– New Matter: any information that cannot be inferred
from application as filed and that is not admitted prior
art
– Adding prior art to support a sound prediction of
utility, where it would not have been clear to one
skilled in the art which of the teachings in the prior art
were necessary for this purpose
Europe – Minimum Requirements
• Article 83 Disclosure of the Invention
– Demonstrate at least one way of carrying out invention that
is performable over whole claim scope
– Repeatability/reproducibility of information – “undue”
experimentation standard
– Sufficiently clear and complete description – Europe has a
stricter written description requirement than the US
• Article 56 Inventive Step
– Application as filed must plausibly demonstrate that the
problem is credibly solved over the whole breadth of the
claims
Europe – Minimum Requirements
• Considerations for satisfying sufficiency of
disclosure and inventive step:
– Include experimental evidence desired technical effect
is achieved (working example), or solution is plausible
in view of background of person of ordinary skill in the
art (prophetic example)
– Evidence that invention can be carried out over whole
breadth of claimed invention
– Data is required for medical use claims
Europe – Post-Filing
• Article 83 Disclosure of the Invention
– Post-filing data is NOT admissible to establish sufficiency of
the original disclosure – must meet minimum requirements
as of filing date
• Article 56 Inventive Step
– Pharma/biological data admissible as long as it merely
proves the technical effect related to originally stated
problem
– Data admissible as long as it merely confirms invention
works and is not used to establish enablement of the
invention – i.e., POC of a prophetic example
China – Minimum Requirements
• Article 26, paragraph 4, of the Patent Law of
the People's Republic of China:
“The claims shall be supported by the description
and shall state the extent of the patent protection
asked for.”
China – Minimum Requirements
• Practical Application:
- Application must include a “sufficient number” of
examples to allow a person skilled in the art to
understand how to carry out the invention and to
determine that the invention, when it is carried out, will
achieve the effect as expected through the entire scope of
the claims.
- “Expectations” set up by disclosure might create issues if
not fully supported by data – don’t overpromise
- Issue related to inventions where the underlying
mechanism of action is not well understood, in
combination with broad claims
China – Minimum Requirements
• Sufficiency Issue
– Disclosure must not only enable one skilled in the art to
carry out the invention, but must enable that person to
readily expect the effects/functions of the claimed invention
to be obtained based upon this disclosure.
• Support Issue
– Strict reading of application disclosure
– “Undue” experimentation is the standard for enablement
– Inclusion of preparation examples and test data regarding
effects is expected
China – Minimum Requirements
• Must also demonstrate that the invention has
an inventive step
– Explanation for inventive step usually needs to be in
line with the expected outcome/data in the application
China – Minimum Requirements
• Considerations for satisfying sufficiency and
support issues and inventive step:
– Set different levels: preferable, more preferable, further
more preferable
– Disclose/describe more alternatives
– Provide more examples
– Include sufficient experimental/test data rather than
declarative conclusions
China – Post-Filing
• Post-filing evidence may be submitted  
– To address rejections related to sufficiency of
disclosure or support, data may be admitted if it is
consistent with the original teachings of the application
as filed.
– To address a rejection based upon of lack of inventive
step, data may be used, so long as it the demonstrated
technical effect is consistent with the original teachings
of the application as filed  
– Prior art documents are also usually admissible
China – Post-Filing
Examiners do not readily accept post-filing data
because of issues related to satisfying the
requirements of: authenticity, legality, and
relevancy
Any Questions?
Tracy Bornman
tbornman@hoveywilliams.com
Crissa A. Seymour Cook
ccook@hoveywilliams.com
© Hovey Williams LLP 2012
Thank You!
Hovey Williams LLP
84 Corporate Woods
10801 Mastin Blvd., Suite 1000
Overland Park, KS 66210
913.647.9050
www.hoveywilliams.com

More Related Content

Viewers also liked (20)

AMEXCAN NCCGP 2013
AMEXCAN NCCGP 2013AMEXCAN NCCGP 2013
AMEXCAN NCCGP 2013
 
Sheryl presentation 5 26 11 version 5 sh2
Sheryl presentation 5 26 11 version 5 sh2Sheryl presentation 5 26 11 version 5 sh2
Sheryl presentation 5 26 11 version 5 sh2
 
Efecto del agente espesante en la liberación de tirosol de natillas
Efecto del agente espesante en la liberación de tirosol de natillas Efecto del agente espesante en la liberación de tirosol de natillas
Efecto del agente espesante en la liberación de tirosol de natillas
 
NittyGritty
NittyGrittyNittyGritty
NittyGritty
 
η φιλια
η φιλιαη φιλια
η φιλια
 
Resourceful Communities NCCGP 2013
Resourceful Communities NCCGP 2013Resourceful Communities NCCGP 2013
Resourceful Communities NCCGP 2013
 
WAVE-X パンフレット
WAVE-X パンフレットWAVE-X パンフレット
WAVE-X パンフレット
 
MainManager CAFM product overview
MainManager CAFM product overviewMainManager CAFM product overview
MainManager CAFM product overview
 
κεφ12
κεφ12κεφ12
κεφ12
 
ανταρκτικη
ανταρκτικηανταρκτικη
ανταρκτικη
 
слайд шоу мбдоу 6
слайд шоу мбдоу 6слайд шоу мбдоу 6
слайд шоу мбдоу 6
 
Onethoritalia Massimo Gentile
Onethoritalia Massimo GentileOnethoritalia Massimo Gentile
Onethoritalia Massimo Gentile
 
2013 NCCGP Annual Members Meeting
2013 NCCGP Annual Members Meeting2013 NCCGP Annual Members Meeting
2013 NCCGP Annual Members Meeting
 
Project
ProjectProject
Project
 
κεφ4
κεφ4κεφ4
κεφ4
 
Network Exploitation
Network ExploitationNetwork Exploitation
Network Exploitation
 
ABCD NCCGP 2013
ABCD NCCGP 2013ABCD NCCGP 2013
ABCD NCCGP 2013
 
Human resources chapter 1
Human resources chapter 1Human resources chapter 1
Human resources chapter 1
 
Mule esb
Mule esbMule esb
Mule esb
 
Rautina ingles
Rautina inglesRautina ingles
Rautina ingles
 

Similar to MO Sept 2014

From Proof of Concept to Patent: The Nitty Gritty About the Patent Process
From Proof of Concept to Patent: The Nitty Gritty About the Patent ProcessFrom Proof of Concept to Patent: The Nitty Gritty About the Patent Process
From Proof of Concept to Patent: The Nitty Gritty About the Patent ProcessHovey Williams LLP
 
Introduction to Patent Law
Introduction to Patent LawIntroduction to Patent Law
Introduction to Patent LawMichael E. Dukes
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Knobbe Martens - Intellectual Property Law
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Knobbe Martens - Intellectual Property Law
 
Patent M.pharm Pharmaceutic$ industry pharmacy
Patent M.pharm Pharmaceutic$ industry pharmacy Patent M.pharm Pharmaceutic$ industry pharmacy
Patent M.pharm Pharmaceutic$ industry pharmacy Abdallah Abdalmalk
 
A Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationA Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationWorkman Nydegger
 
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...Knobbe Martens - Intellectual Property Law
 
Patent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsPatent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsAurora Consulting
 
America Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act:  Recent Changes to US Patent Law and PracticeAmerica Invents Act:  Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and PracticeGary M. Myles, Ph.D.
 
The Pitch on Patent Reform
The Pitch on Patent ReformThe Pitch on Patent Reform
The Pitch on Patent ReformMichael Annis
 
Novelty search USA & Canada | Patentability Search | InventionIP
Novelty search USA & Canada | Patentability Search | InventionIPNovelty search USA & Canada | Patentability Search | InventionIP
Novelty search USA & Canada | Patentability Search | InventionIPInvention ip
 
COER 13-2-2008.pdf
COER 13-2-2008.pdfCOER 13-2-2008.pdf
COER 13-2-2008.pdfssuser996f71
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Knobbe Martens - Intellectual Property Law
 

Similar to MO Sept 2014 (20)

From Proof of Concept to Patent: The Nitty Gritty About the Patent Process
From Proof of Concept to Patent: The Nitty Gritty About the Patent ProcessFrom Proof of Concept to Patent: The Nitty Gritty About the Patent Process
From Proof of Concept to Patent: The Nitty Gritty About the Patent Process
 
Introduction to Patent Law
Introduction to Patent LawIntroduction to Patent Law
Introduction to Patent Law
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
 
PATENT APPLICATION & REGISTRATION PROCESS
PATENT APPLICATION & REGISTRATION PROCESSPATENT APPLICATION & REGISTRATION PROCESS
PATENT APPLICATION & REGISTRATION PROCESS
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
 
Patent M.pharm Pharmaceutic$ industry pharmacy
Patent M.pharm Pharmaceutic$ industry pharmacy Patent M.pharm Pharmaceutic$ industry pharmacy
Patent M.pharm Pharmaceutic$ industry pharmacy
 
basiclaw.ppt
basiclaw.pptbasiclaw.ppt
basiclaw.ppt
 
A Walk-through of Supplemental Examination
A Walk-through of Supplemental ExaminationA Walk-through of Supplemental Examination
A Walk-through of Supplemental Examination
 
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...
Knobbe Practice Webinar Series: Strategic Considerations for Patent Prosecuti...
 
Patent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger PatentsPatent Searching: Sleuthing Your Way to Stronger Patents
Patent Searching: Sleuthing Your Way to Stronger Patents
 
August 2014 Patent Prosecution Lunch Presentation
August 2014 Patent Prosecution Lunch PresentationAugust 2014 Patent Prosecution Lunch Presentation
August 2014 Patent Prosecution Lunch Presentation
 
Introduction to patents
Introduction to patentsIntroduction to patents
Introduction to patents
 
"Patent Applications"
"Patent Applications""Patent Applications"
"Patent Applications"
 
Patent Search & Drafting Patent Claims
Patent Search & Drafting Patent ClaimsPatent Search & Drafting Patent Claims
Patent Search & Drafting Patent Claims
 
America Invents Act: Recent Changes to US Patent Law and Practice
America Invents Act:  Recent Changes to US Patent Law and PracticeAmerica Invents Act:  Recent Changes to US Patent Law and Practice
America Invents Act: Recent Changes to US Patent Law and Practice
 
The Pitch on Patent Reform
The Pitch on Patent ReformThe Pitch on Patent Reform
The Pitch on Patent Reform
 
Novelty search USA & Canada | Patentability Search | InventionIP
Novelty search USA & Canada | Patentability Search | InventionIPNovelty search USA & Canada | Patentability Search | InventionIP
Novelty search USA & Canada | Patentability Search | InventionIP
 
COER 13-2-2008.pdf
COER 13-2-2008.pdfCOER 13-2-2008.pdf
COER 13-2-2008.pdf
 
IPR Presentation
IPR PresentationIPR Presentation
IPR Presentation
 
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
Protecting Your Intellectual Property: Cost-Saving Techniques, Legal Updates ...
 

MO Sept 2014

  • 1. To File or Not to File: Threshold Patent Application Disclosure Requirements and Post-Filing Evidence Admissibility in the U.S. and Foreign Countries Presented By Tracy Bornman Crissa A. Seymour Cook Thursday, September 11, 2014  University of Missouri System
  • 2. What and When? • What kind of information, data, disclosure is needed for meeting threshold requirements in various countries? • When do you need to/When can you present this information, data, disclosure? • What are the pitfalls and best practices?
  • 3. United States • Major issues: – Written Description – Enablement – Best Mode – Definiteness • Addressed in 35 U.S.C. 112 • Inverse relationship to the level of “predictability” of the field of the invention
  • 4. US – Minimum Requirements • Written Description – Description of invention that demonstrates possession of invention as of filing date • Enablement – Describe how to make and use invention • Working examples, Prophetic examples • Figures – Some experimentation permitted…must not be undue • Best Mode? Best practice to still include • Definiteness: clarity and precision in terminology
  • 5. United States – What and When? • Written description, enablement, best mode, and definiteness must be satisfied at time of filing. • How? – Provide text to support different embodiments – Include as much relevant data as possible – Working examples typically included and generally recommended – Detailed drawing figures (picture worth a thousand words)
  • 6. United States – Post-Filing • During patent prosecution, evidence may be submitted to show: – Sufficiency of original disclosure • e.g., in vitro and/or in vivo test results consistent with teachings of specification – Utility/Enablement- operability of claimed invention – confirmation of asserted utility – Novelty- rebut allegation of inherency in prior art, demonstrate prior art is non-enabling – Nonobviousness- secondary considerations, e.g., unexpected results, commercial success – Establish level and knowledge of one of ordinary skill in the art
  • 7. United States – Post-Filing • During prosecution, evidence may NOT be submitted to: – Add new matter or data to the application – Demonstrate that the invention has now been enabled • Any evidence must have a basis in the original filing, or be used to support original disclosure, and consistent with original disclosure
  • 8. Canada – Minimum Requirements • Similar disclosure requirements as the U.S., set forth in section 27 of the Canadian patent act: – “Correct” and “full” description of the invention – Enabling disclosure – “undue” experimentation standard – Best Mode – Process claims require a description of the necessary sequence, if applicable • Utility – higher threshold
  • 9. Canada – Minimum Requirements • Utility Requirement – evolving issue – Inventor has actually demonstrated utility prior to the application filing date, or – Inventor has data and a line of reasoning for sound prediction of utility – “Promise Doctrine” – what utility does the disclosure promise of the invention?
  • 10. Canada – Minimum Requirements • Promise Doctrine: – Requires the inventor to “soundly predict” how its invention will be used and essentially prove via data in the application hat the invention will successfully fulfill its promise • Considerations for satisfying utility: – Avoid “over promising” - Do not include statements in the description that could be read as a promise of a utility that is not clearly supported – Provide explicit statement linking data to utility and align claim scope accordingly.
  • 11. Canada – Post-Filing • Post-filing evidence that is admissible: – Adding matter that can be reasonably inferred from application as filed – Incorporating prior art so long as it is admitted* in the specification that the matter is prior art with respect to the application (benefit must be weighed against treatment of admissions in U.S.) • Canadian Examiners are under no obligation to review post-filing submissions.
  • 12. Canada – Post-Filing • Post-filing evidence that is NOT admissible: – Post-filing data is not permitted to support predictions about a claim’s utility or soundness.  – New Matter: any information that cannot be inferred from application as filed and that is not admitted prior art – Adding prior art to support a sound prediction of utility, where it would not have been clear to one skilled in the art which of the teachings in the prior art were necessary for this purpose
  • 13. Europe – Minimum Requirements • Article 83 Disclosure of the Invention – Demonstrate at least one way of carrying out invention that is performable over whole claim scope – Repeatability/reproducibility of information – “undue” experimentation standard – Sufficiently clear and complete description – Europe has a stricter written description requirement than the US • Article 56 Inventive Step – Application as filed must plausibly demonstrate that the problem is credibly solved over the whole breadth of the claims
  • 14. Europe – Minimum Requirements • Considerations for satisfying sufficiency of disclosure and inventive step: – Include experimental evidence desired technical effect is achieved (working example), or solution is plausible in view of background of person of ordinary skill in the art (prophetic example) – Evidence that invention can be carried out over whole breadth of claimed invention – Data is required for medical use claims
  • 15. Europe – Post-Filing • Article 83 Disclosure of the Invention – Post-filing data is NOT admissible to establish sufficiency of the original disclosure – must meet minimum requirements as of filing date • Article 56 Inventive Step – Pharma/biological data admissible as long as it merely proves the technical effect related to originally stated problem – Data admissible as long as it merely confirms invention works and is not used to establish enablement of the invention – i.e., POC of a prophetic example
  • 16. China – Minimum Requirements • Article 26, paragraph 4, of the Patent Law of the People's Republic of China: “The claims shall be supported by the description and shall state the extent of the patent protection asked for.”
  • 17. China – Minimum Requirements • Practical Application: - Application must include a “sufficient number” of examples to allow a person skilled in the art to understand how to carry out the invention and to determine that the invention, when it is carried out, will achieve the effect as expected through the entire scope of the claims. - “Expectations” set up by disclosure might create issues if not fully supported by data – don’t overpromise - Issue related to inventions where the underlying mechanism of action is not well understood, in combination with broad claims
  • 18. China – Minimum Requirements • Sufficiency Issue – Disclosure must not only enable one skilled in the art to carry out the invention, but must enable that person to readily expect the effects/functions of the claimed invention to be obtained based upon this disclosure. • Support Issue – Strict reading of application disclosure – “Undue” experimentation is the standard for enablement – Inclusion of preparation examples and test data regarding effects is expected
  • 19. China – Minimum Requirements • Must also demonstrate that the invention has an inventive step – Explanation for inventive step usually needs to be in line with the expected outcome/data in the application
  • 20. China – Minimum Requirements • Considerations for satisfying sufficiency and support issues and inventive step: – Set different levels: preferable, more preferable, further more preferable – Disclose/describe more alternatives – Provide more examples – Include sufficient experimental/test data rather than declarative conclusions
  • 21. China – Post-Filing • Post-filing evidence may be submitted   – To address rejections related to sufficiency of disclosure or support, data may be admitted if it is consistent with the original teachings of the application as filed. – To address a rejection based upon of lack of inventive step, data may be used, so long as it the demonstrated technical effect is consistent with the original teachings of the application as filed   – Prior art documents are also usually admissible
  • 22. China – Post-Filing Examiners do not readily accept post-filing data because of issues related to satisfying the requirements of: authenticity, legality, and relevancy
  • 23. Any Questions? Tracy Bornman tbornman@hoveywilliams.com Crissa A. Seymour Cook ccook@hoveywilliams.com © Hovey Williams LLP 2012
  • 24. Thank You! Hovey Williams LLP 84 Corporate Woods 10801 Mastin Blvd., Suite 1000 Overland Park, KS 66210 913.647.9050 www.hoveywilliams.com